WG5. Biomarkers of Metastatic ILC

Leadership

Amanda Fitzpatrick
Amanda Fitzpatrick

KCL and GUY'S

Christine Desmedt
Christine Desmedt

KU LEUVEN

Sylvia Knoll
Sylvia Knoll

PA (AUSTRIA)

Andrea Lener
Andrea Lener

PA (ISLE OF MAN)

Participants

Anastasios Papanastasiou University of West Attica
Anya Nicholas Institute of Cancer Research
Caroline Malhaire Institut Curie
Clare Isacke Institute of Cancer Research
Colinda Scheele VIB-KU Leuven Center for Cancer Biology
Esme Bullock Institute of Cancer Research
Georgios Skiadas Institute of Cancer Research
Guillerme Nader Marta Dana-Farber Cancer Institute
Hannah Wen MSK Cancer Center
Jorine Sanders UMC Utrecht
Marco Antonio Rioja Vega INEN
Maria Gabriela Raso MD Anderson Cancer Center
Meritxell Bellet Vall d Hebron University Hospital and VHIO
Patrick Derksen UMC Utrecht
Rachael Natrajan Institute of Cancer Research
Rachel Jankowitz University of Pennsylvania
Renee Flaherty Institute of Cancer Research
Richard ‘s Heeren KU Leuven
Sai Maley NSABP Foundation
Sankari Nagarajan The University of Manchester
Santiago Madera Institute of Cancer Research
Sonia Pernas Catalan Institute of Oncology
Susan Fineberg Montefiore Medical Center
Syed Haider The ICR
Thurkaa Shanmugalingam King’s College London

Past and Future meetings

TBD

Info here.

TBD

Info here.

Activities

The Biomarkers of Metastatic ILC working group has been newly formed in 2025. Come back later for more content.